Skeletal muscle wasting: New role of nonclassical renin-angiotensin system

Claudio Cabello-Verrugio, Juan C. Rivera, Dominga Garcia

Resultado de la investigación: Contribución a la publicaciónReview article

Resumen

Purpose of review Skeletal muscle can be affected by many physiological and pathological conditions that contribute to the development of muscle weakness, including skeletal muscle loss, inflammatory processes, or fibrosis. Therefore, research into therapeutic treatment alternatives or alleviation of these effects on skeletal muscle is of great importance. Recent findings Recent studies have shown that angiotensin (1-7) [Ang-(1-7)]- A vasoactive peptide of the nonclassical axis in the renin-angiotensin system (RAS)- A nd its Mas receptor are expressed in skeletal muscle. Ang-(1-7), through its Mas receptor, prevents or diminishes deleterious effects induced by skeletal muscle disease or injury. Specifically, the Ang-(1-7)-Mas receptor axis modulates molecular mechanisms involved in muscle mass regulation, such as the ubiquitin proteasome pathway, the insulin-like growth factor type 1/Akt (protein kinase B) pathway, or myonuclear apoptosis, and also inflammation and fibrosis pathways. Summary Although further research into this topic and the possible side effects of Ang-(1-7) is necessary, these findings are promising, and suggest that the Ang-(1-7)-Mas axis can be considered a possible therapeutic target for treating patients with muscular disorders.

IdiomaEnglish
Páginas158-163
Número de páginas6
PublicaciónCurrent Opinion in Clinical Nutrition and Metabolic Care
Volumen20
Número de edición3
DOI
EstadoPublished - 1 may 2017

Huella dactilar

Renin-Angiotensin System
Skeletal Muscle
Fibrosis
Therapeutic Human Experimentation
Proto-Oncogene Proteins c-akt
Muscle Weakness
Somatomedins
Proteasome Endopeptidase Complex
Ubiquitin
angiotensin I (1-7)
Apoptosis
Inflammation
Muscles
Peptides
Wounds and Injuries
Therapeutics
Research

Keywords

    ASJC Scopus subject areas

    • Medicine (miscellaneous)
    • Nutrition and Dietetics

    Citar esto

    @article{494ed543360a4c7ea4409f022b83a370,
    title = "Skeletal muscle wasting: New role of nonclassical renin-angiotensin system",
    abstract = "Purpose of review Skeletal muscle can be affected by many physiological and pathological conditions that contribute to the development of muscle weakness, including skeletal muscle loss, inflammatory processes, or fibrosis. Therefore, research into therapeutic treatment alternatives or alleviation of these effects on skeletal muscle is of great importance. Recent findings Recent studies have shown that angiotensin (1-7) [Ang-(1-7)]- A vasoactive peptide of the nonclassical axis in the renin-angiotensin system (RAS)- A nd its Mas receptor are expressed in skeletal muscle. Ang-(1-7), through its Mas receptor, prevents or diminishes deleterious effects induced by skeletal muscle disease or injury. Specifically, the Ang-(1-7)-Mas receptor axis modulates molecular mechanisms involved in muscle mass regulation, such as the ubiquitin proteasome pathway, the insulin-like growth factor type 1/Akt (protein kinase B) pathway, or myonuclear apoptosis, and also inflammation and fibrosis pathways. Summary Although further research into this topic and the possible side effects of Ang-(1-7) is necessary, these findings are promising, and suggest that the Ang-(1-7)-Mas axis can be considered a possible therapeutic target for treating patients with muscular disorders.",
    keywords = "Angiotensin-(1-7), Mas receptor, muscle weakness",
    author = "Claudio Cabello-Verrugio and Rivera, {Juan C.} and Dominga Garcia",
    year = "2017",
    month = "5",
    day = "1",
    doi = "10.1097/MCO.0000000000000361",
    language = "English",
    volume = "20",
    pages = "158--163",
    journal = "Current Opinion in Clinical Nutrition and Metabolic Care",
    issn = "1363-1950",
    publisher = "Lippincott Williams and Wilkins",
    number = "3",

    }

    Skeletal muscle wasting : New role of nonclassical renin-angiotensin system. / Cabello-Verrugio, Claudio; Rivera, Juan C.; Garcia, Dominga.

    En: Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 20, N.º 3, 01.05.2017, p. 158-163.

    Resultado de la investigación: Contribución a la publicaciónReview article

    TY - JOUR

    T1 - Skeletal muscle wasting

    T2 - Current Opinion in Clinical Nutrition and Metabolic Care

    AU - Cabello-Verrugio,Claudio

    AU - Rivera,Juan C.

    AU - Garcia,Dominga

    PY - 2017/5/1

    Y1 - 2017/5/1

    N2 - Purpose of review Skeletal muscle can be affected by many physiological and pathological conditions that contribute to the development of muscle weakness, including skeletal muscle loss, inflammatory processes, or fibrosis. Therefore, research into therapeutic treatment alternatives or alleviation of these effects on skeletal muscle is of great importance. Recent findings Recent studies have shown that angiotensin (1-7) [Ang-(1-7)]- A vasoactive peptide of the nonclassical axis in the renin-angiotensin system (RAS)- A nd its Mas receptor are expressed in skeletal muscle. Ang-(1-7), through its Mas receptor, prevents or diminishes deleterious effects induced by skeletal muscle disease or injury. Specifically, the Ang-(1-7)-Mas receptor axis modulates molecular mechanisms involved in muscle mass regulation, such as the ubiquitin proteasome pathway, the insulin-like growth factor type 1/Akt (protein kinase B) pathway, or myonuclear apoptosis, and also inflammation and fibrosis pathways. Summary Although further research into this topic and the possible side effects of Ang-(1-7) is necessary, these findings are promising, and suggest that the Ang-(1-7)-Mas axis can be considered a possible therapeutic target for treating patients with muscular disorders.

    AB - Purpose of review Skeletal muscle can be affected by many physiological and pathological conditions that contribute to the development of muscle weakness, including skeletal muscle loss, inflammatory processes, or fibrosis. Therefore, research into therapeutic treatment alternatives or alleviation of these effects on skeletal muscle is of great importance. Recent findings Recent studies have shown that angiotensin (1-7) [Ang-(1-7)]- A vasoactive peptide of the nonclassical axis in the renin-angiotensin system (RAS)- A nd its Mas receptor are expressed in skeletal muscle. Ang-(1-7), through its Mas receptor, prevents or diminishes deleterious effects induced by skeletal muscle disease or injury. Specifically, the Ang-(1-7)-Mas receptor axis modulates molecular mechanisms involved in muscle mass regulation, such as the ubiquitin proteasome pathway, the insulin-like growth factor type 1/Akt (protein kinase B) pathway, or myonuclear apoptosis, and also inflammation and fibrosis pathways. Summary Although further research into this topic and the possible side effects of Ang-(1-7) is necessary, these findings are promising, and suggest that the Ang-(1-7)-Mas axis can be considered a possible therapeutic target for treating patients with muscular disorders.

    KW - Angiotensin-(1-7)

    KW - Mas receptor

    KW - muscle weakness

    UR - http://www.scopus.com/inward/record.url?scp=85013078009&partnerID=8YFLogxK

    U2 - 10.1097/MCO.0000000000000361

    DO - 10.1097/MCO.0000000000000361

    M3 - Review article

    VL - 20

    SP - 158

    EP - 163

    JO - Current Opinion in Clinical Nutrition and Metabolic Care

    JF - Current Opinion in Clinical Nutrition and Metabolic Care

    SN - 1363-1950

    IS - 3

    ER -